GlassScriptPhysician profile
Mitra Dastgheyb
NPI 1831287739
$396.59
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.07 · 2020: $52.45 · 2021: $149 · 2022: $83.96 · 2024: $59.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $59.40 | 2021 | |
| Medtronic, INC. | $59.15 | 2024 | Minimed 780g |
| Lilly USA, LLC | $52.70 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $52.07 | 2019 | |
| Abbott Laboratories | $37.16 | 2021-2022 | |
| Abbvie INC. | $29.78 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $25.28 | 2022 | |
| Amneal Pharmaceuticals LLC | $23.94 | 2021 | |
| Corcept Therapeutics | $23.18 | 2022 | |
| Ibsa Pharma INC. | $21.17 | 2021 | |
| Novo Nordisk INC | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitra Dastgheyb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.